Tuberculosis Diagnostics Global Market Report 2025

Tuberculosis Diagnostics Market Report 2023

Tuberculosis Diagnostics Global Market Report 2025 – By Test Type (Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types), By Disease Stage (Latent Tuberculosis, Active Tuberculosis), By End-User (Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities) – Market Size, Trends, And Global Forecast 2025-2034

Name: Tuberculosis Diagnostics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Tuberculosis Diagnostics Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Tuberculosis Diagnostics Global Market Report 2025

Proud Members Of

Tuberculosis Diagnostics Market Definition

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

The various types of tuberculosis diagnostic markets include radiographic testing, laboratory testing, Nucleic Acid Testing, cytokine detection testing, drug resistance testing, skin test or Mantoux test (TST), blood/serology test, smear microscopy tests, cell culture-based tests, and others. Radiographic tests are used to detect chest abnormalities in the case of tuberculosis symptoms. The radiographic test refers to the diagnosis of lesions that may develop anywhere in the lungs and vary in terms of cavitation, density, size, and shape. The tests include nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and others, used for disease stages such as latent tuberculosis and active tuberculosis. The end-users of tuberculosis diagnostics include hospitals and diagnostic laboratories, physician’s office laboratories, reference laboratories, academic institutions, and research facilities.

Tuberculosis Diagnostics Market Segmentation

The tuberculosis diagnostics market covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Tuberculosis Diagnostics Market Size and growth rate 2025 to 2029: Graph

Tuberculosis Diagnostics Market Size 2025 And Growth Rate

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities, and the rise in the adoption of nucleic acid testing.

Tuberculosis Diagnostics Market Growth Forecast

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.24 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities, and the emergence of drug-resistant TB. Major trends in the forecast period include a focus on next-generation sequencing (NGS) platforms for TB diagnostics, product innovations, t-cell tests for TB infection, artificial intelligence (AI)-based tuberculosis diagnostics, use of portable devices, and collaborations between governments and manufacturers.

Book your 30 minutes free consultation with our research experts

Tuberculosis Diagnostics Market Driver: Tuberculosis Diagnostics In Response To Rising Incidence

The rise in the incidence of tuberculosis is driving the demand for the tuberculosis diagnostics market going forward. Tuberculosis is an infectious disease that affects the lungs and can be severe. Tuberculosis is spread through coughing and sneezing, releasing tiny germs into the air. Tuberculosis diagnostics aid in patient detection, with earlier diagnosis and detection of diseases. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Therefore, the rise in the incidence of tuberculosis drives the tuberculosis diagnostics market. Therefore, the rise in the incidence of tuberculosis is driving the growth of the tuberculosis diagnostics market.

Tuberculosis Diagnostics Market Driver: FDA Approvals Driving Growth In Tuberculosis Diagnostics Market

During the forecast period, the increasing US Food and Drug Administration (FDA) approvals for tuberculosis diagnostics will support the growth of the tuberculosis diagnostics market. For example, in March 2023, PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, announced that the US FDA has approved the use of two additional cell isolation instruments Auto-Pure 24 and Auto-Pure 20B platforms manufactured by Allsheng Instruments. Further, in October 2022, PerkinElmer Oxford Immunotec announced that the FDA has approved the use of the T-Cell Select reagent kit for the automation of its T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select is a peripheral blood mononuclear cell (PBMC) isolation reagent that uses positive selection of PBMCs with magnetic bead-based cell separation to automate and simplify the preparation of cells for the T-SPOT.TB test, a globally regulated ELISPOT IGRA for detecting latent TB infection. Therefore, the increasing approvals for new tuberculosis diagnostics will support the growth of the tuberculosis diagnostics market.

Global Tuberculosis Diagnostics Market Major Players

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Global Tuberculosis Diagnostics Market Trend: Tech Advancements Transforming Tuberculosis Diagnostics Market

Technological innovations are the key trend gaining popularity in the tuberculosis diagnostics market. Major companies operating in the market are introducing new technologies, such as advanced point-of-care (POC) diagnostic methods that work on AI technology to sustain their position in the market. For instance, in August 2022, Fujifilm, a Japan-based company engaged in the manufacturing of medical imaging devices, partnered with Qure.ai, a US-based company engaged in the development of AI-enabled medical imaging solutions, and launched an advanced point-of-care (POC) diagnostic method. A battery-powered X-ray machine is used in this method for tuberculosis diagnosis. With the help of artificial intelligence, algorithms help in effective testing programs, offering ultra-portability, high accuracy, and efficient point-of-care diagnostic solutions.

Global Tuberculosis Diagnostics Market Trend: Product Innovations Driving Tuberculosis Diagnostics

Product innovations are a key trend in the tuberculosis diagnostics market, as companies look to stay competitive and meet the evolving needs and preferences of consumers. The innovation in a product can generate buzz and excitement, which can drive sales and increase brand awareness. Companies in the tuberculosis diagnostics market are focusing on product innovations and developing new product solutions to strengthen their position in the market. For example, in February 2023, Redcliffe Labs, an India-based technology-empowered diagnostics service provider, launched the BD MAX MDR TB (Tuberculosis) test, a diagnostic test to enable clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test, which is performed on BD MAX molecular diagnostic system. Clinicians use the test to simultaneously detect bacteria that cause TB and determine if the bacteria contain mutations associated with resistance to two important first-line drugs, Isoniazid (INH) and Rifampicin (RIF).

Tuberculosis Diagnostics Market Merger And Acquisition: Danaher Corporation Acquisition Of Abcam plc To Enhance Danaher’s Life Sciences Segment

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc, foran undisclosed amount. With this acquisition, Danaher Corporation seeks to strengthen its position in the life sciences sector by leveraging Abcam plc's extensive portfolio of high-quality reagents and antibodies, thereby enhancing its capabilities in scientific research and development to better serve the growing demand for advanced biological research tools.. Abcam plc isa UK-based biotechnology company that offers tuberculosis diagnostics.

Regional Outlook For The Global Tuberculosis Diagnostics Market

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Tuberculosis Diagnostics Market?

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tuberculosis Diagnostics Industry?

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Tuberculosis Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.36 billion
Revenue Forecast In 2034	$3.24 billion
Growth Rate	CAGR of 8.2% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types 2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis 3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities Subsegments: 1) By Radiographic Tests: Chest X-rays, CT Scans 2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs) 3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs) 4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays 5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST) 6) By Blood Or Serology Test: Serological Tests for Antibodies 7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test 8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures 9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Tuberculosis Diagnostics Market Characteristics

3. Tuberculosis Diagnostics Market Trends And Strategies

4. Tuberculosis Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Tuberculosis Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Tuberculosis Diagnostics Market Growth Rate Analysis

5.4. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Tuberculosis Diagnostics Total Addressable Market (TAM)

6. Tuberculosis Diagnostics Market Segmentation

6.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Radiographic Tests

Nucleic Acid Testing

Cytokine Detection Tests

Drug Resistance Tests

Skin Test / Mantoux Test (TST)

Blood/Serology Test

Smear Microscopy Tests

Cell Culture-Based Tests

Other Test Types

6.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Latent Tuberculosis

Active Tuberculosis

6.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Diagnostic Laboratories

Physician’s Office Laboratories

Reference Laboratories

Academics And Research Facilities

6.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chest X-rays

CT Scans

6.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction (PCR)

Nucleic Acid Amplification Tests (NAATs)

6.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Interferon Gamma Release Assays (IGRAs)

6.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

GeneXpert MTB/RIF

Line Probe Assays

6.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tuberculin Skin Test (TST)

6.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Serological Tests for Antibodies

6.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acid-Fast Bacilli (AFB) Smear Test

6.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Solid Media Cultures

Liquid Media Cultures

6.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Molecular Tests

Advanced Imaging Techniques

7. Tuberculosis Diagnostics Market Regional And Country Analysis

7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tuberculosis Diagnostics Market

8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tuberculosis Diagnostics Market

9.1. China Tuberculosis Diagnostics Market Overview

9.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tuberculosis Diagnostics Market

10.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tuberculosis Diagnostics Market

11.1. Japan Tuberculosis Diagnostics Market Overview

11.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tuberculosis Diagnostics Market

12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tuberculosis Diagnostics Market

13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tuberculosis Diagnostics Market

14.1. South Korea Tuberculosis Diagnostics Market Overview

14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tuberculosis Diagnostics Market

15.1. Western Europe Tuberculosis Diagnostics Market Overview

15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tuberculosis Diagnostics Market

16.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tuberculosis Diagnostics Market

17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tuberculosis Diagnostics Market

18.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tuberculosis Diagnostics Market

19.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tuberculosis Diagnostics Market

20.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tuberculosis Diagnostics Market

21.1. Eastern Europe Tuberculosis Diagnostics Market Overview

21.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tuberculosis Diagnostics Market

22.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tuberculosis Diagnostics Market

23.1. North America Tuberculosis Diagnostics Market Overview

23.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tuberculosis Diagnostics Market

24.1. USA Tuberculosis Diagnostics Market Overview

24.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tuberculosis Diagnostics Market

25.1. Canada Tuberculosis Diagnostics Market Overview

25.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tuberculosis Diagnostics Market

26.1. South America Tuberculosis Diagnostics Market Overview

26.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tuberculosis Diagnostics Market

27.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tuberculosis Diagnostics Market

28.1. Middle East Tuberculosis Diagnostics Market Overview

28.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tuberculosis Diagnostics Market

29.1. Africa Tuberculosis Diagnostics Market Overview

29.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

30.1. Tuberculosis Diagnostics Market Competitive Landscape

30.2. Tuberculosis Diagnostics Market Company Profiles

30.2.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis

30.2.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tuberculosis Diagnostics Market Other Major And Innovative Companies

31.1. PerkinElmer

31.2. Thermo Fisher Scientific Inc.

31.3. Creative Diagnostics

31.4. Lionex GmbH

31.5. Biocartis

31.6. Bio-Techne India Private Limited

31.7. Bio-Rad Laboratories India Pvt.Ltd

31.8. Zhejiang Di'an Diagnostics Technology Co., Ltd

31.9. ADICON Clinical Laboratories

31.10. Guangzhou Kingmed Diagnostics Center Co. Ltd.

31.11. Kindstar Global

31.12. OriGene Technologies

31.13. Siemens AG

31.14. LumiraDx Limited

31.15. TestLine Clinical Diagnostics s.r.o.

32. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

34. Recent Developments In The Tuberculosis Diagnostics Market

35. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Tuberculosis Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Tuberculosis Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Tuberculosis Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: China, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: China, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: India, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: India, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Japan, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Japan, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Australia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Australia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Indonesia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: South Korea, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: South Korea, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Western Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: UK, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: UK, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Germany, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Germany, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: France, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: France, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Italy, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Italy, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Spain, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Spain, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Russia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Russia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: North America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: North America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: USA, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: USA, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Canada, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Canada, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: South America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: South America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Brazil, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Brazil, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Middle East, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Middle East, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Africa, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 82: Africa, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 83: Beckton, Dickinson and Company Financial Performance

Table 84: F. Hoffmann-La Roche Ltd Financial Performance

Table 85: Qiagen N.V Financial Performance

Table 86: BioMerieux SA Financial Performance

Table 87: Danaher Corporation Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: China, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: China, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: India, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: India, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Japan, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Japan, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Australia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Australia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Indonesia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: South Korea, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: South Korea, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Western Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: UK, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: UK, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Germany, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Germany, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: France, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: France, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Italy, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Italy, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Spain, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Spain, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Russia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Russia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: North America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: North America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: USA, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: USA, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Canada, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Canada, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: South America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: South America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Brazil, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Brazil, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Middle East, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Middle East, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Africa, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 82: Africa, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 83: Beckton, Dickinson and Company Financial Performance

Figure 84: F. Hoffmann-La Roche Ltd Financial Performance

Figure 85: Qiagen N.V Financial Performance

Figure 86: BioMerieux SA Financial Performance

Figure 87: Danaher Corporation Financial Performance

Global Anesthesia And Respiratory Devices Market 2022 – Market Opportunities And Strategies

The Diabetes Care Devices Market Share, Market Size, And Growth Rate 2022

The Drug Delivery Devices Market Share, Market Size, And Growth Rate 2022

Latest ENT Devices Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the single use assemblies market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the temperature monitoring devices market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the urinary incontinence and pelvic organ prolapse devices and equipment market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the trauma fixation devices and equipment research report 2022 with industry size, share, segments and market growth

Molecular Diagnostics Global Market Report 2022 – By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing), By Product (Instruments, Reagents and Consumables, Software and Services), By Application (Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Other Applications), By End-User (Hospitals, Laboratories, and Other End-Users (Blood Banks, Home Health Agencies, and Nursing Homes) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Respiratory Disposables Global Market Report 2025 – By Type (Masks, Tubes, Inhalers, Other Types), By Disease Indications (Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respiratory Diseases), By Application (Adult, Pediatric & Neonatal), By End User (Hospitals, Clinics, Ambulatory Care Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Respiratory Devices And Equipment (Therapeutic) Global Market Report 2025 – By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers), By Technology (HEPA Filter, Electrostatic Filtration, Microsphere Separation, Hollow Fiber Filtration, Other Technologies), By End-User (Homecare settings, Hospitals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Transplant Diagnostics Global Market Report 2025 – By Type (Reagent & Consumables, Instrument, Software & Services), By Transplant Type (Solid Organ, Stem Cell), By Organ (Kidney, Liver, Heart, Lung, Pancreas), By Technology (Non Molecular Assay, Molecular Assay), By End User (Hospitals and Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Blood Transfusion Diagnostics Global Market Report 2025 – By Type (Instruments and Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Molecular Diagnostics Devices And Equipment Global Market Report 2025 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications), By End User (Diagnostic laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Tuberculosis Diagnostics market?

How will the Tuberculosis Diagnostics market drivers and restraints affect the market dynamics? What forces will shape the Tuberculosis Diagnostics industry going forward?

The Tuberculosis Diagnostics market major growth driver - Tuberculosis Diagnostics In Response To Rising Incidence. For further insights on the Tuberculosis Diagnostics market, request a sample here

What is the forecast market size or the forecast market value of the Tuberculosis Diagnostics market?

The Tuberculosis Diagnostics market size has grown strongly in recent years. The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities, and the rise in the adoption of nucleic acid testing. The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.24 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities, and the emergence of drug-resistant TB. Major trends in the forecast period include a focus on next-generation sequencing (NGS) platforms for TB diagnostics, product innovations, t-cell tests for TB infection, artificial intelligence (AI)-based tuberculosis diagnostics, use of portable devices, and collaborations between governments and manufacturers. For further insights on the Tuberculosis Diagnostics market, request a sample here

How is the Tuberculosis Diagnostics market segmented?

The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques For further insights on the Tuberculosis Diagnostics market, request a sample here

Which region has the largest share of the Tuberculosis Diagnostics market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Tuberculosis Diagnostics market, request a sample here.

Who are the major players in the Tuberculosis Diagnostics market?

What are the key trends in the Tuberculosis Diagnostics market?

Major trends in the Tuberculosis Diagnostics market include Tech Advancements Transforming Tuberculosis Diagnostics Market. For further insights on the Tuberculosis Diagnostics market, request a sample here.

What are the major opportunities in the Tuberculosis Diagnostics market? What are the strategies for the Tuberculosis Diagnostics market?

For detailed insights on the major opportunities and strategies in the Tuberculosis Diagnostics market, request a sample here.

How does the Tuberculosis Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Tuberculosis Diagnostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Tuberculosis Diagnostics industry?

For detailed insights on the mergers and acquisitions in the Tuberculosis Diagnostics industry, request a sample here.

What are the key dynamics influencing the Tuberculosis Diagnostics market growth? SWOT analysis of the Tuberculosis Diagnostics market.

For detailed insights on the key dynamics influencing the Tuberculosis Diagnostics market growth and SWOT analysis of the Tuberculosis Diagnostics industry, request a sample here.